Overview
Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis
Status:
Completed
Completed
Trial end date:
2011-05-01
2011-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bausch & Lomb IncorporatedTreatments:
Bepotastine besilate
Criteria
Inclusion Criteria:- Male or female at least 12 years of age with a history of mountain cedar allergy
Exclusion Criteria:
- No active nasal infection or nasal abnormality that would affect subject safety or
symptom assessments